Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility Academic Article uri icon

Overview

MeSH Major

  • Antigens, Human Platelet
  • Fetal Diseases
  • Immunoglobulins, Intravenous
  • Platelet Count
  • Thrombocytopenia

abstract

  • In fetal alloimmune thrombocytopenia secondary to Pl(A1) platelet antigen incompatibility, fetuses with platelet counts > 20,000 per microliter at the initiation of therapy were predicted to maintain their platelet count at the second fetal blood sampling at > 20,000 per microliter. The characteristics of the previous sibling, as previously reported, did not predict the initial fetal blood sampling, the second fetal blood sampling, or the response to treatment.

publication date

  • October 30, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1067/mob.2001.117668

PubMed ID

  • 11641688

Additional Document Info

start page

  • 976

end page

  • 80

volume

  • 185

number

  • 4